Home › Study helps assess biosimilarity of protein drugs.
 

Keywords :   


Study helps assess biosimilarity of protein drugs.

2016-02-10 14:31:07| Industrial Newsroom - All News for Today

Interlaboratory study of 4 versions of a therapeutic protein drug—all manufactured from living cells—reports that an established analytical tool akin to magnetic resonance imaging reliably assessed atomic structures of biologically similar products, yielding equivalent of a fingerprint for each. Described in Nature Biotechnology, findings demonstrate that 2D nuclear magnetic resonance spectroscopy can be a powerful complementary technique for companies and regulators when assessing biosimilars.

Tags: study helps drugs assess

Category:Industrial Goods and Services

Latest from this category

All news
15.05Relationship Reviews Strengthening the Partnership Between Manufacturer and Rep
14.05Consolidated Financial Statements for the twelve-month period ended March 31, 2024
14.05Actions to Implement Management that is Conscious of Cost of Capital and Stock Price
Industrial Goods and Services »
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
More »